Quest Diagnostics - Comparative Multiple Analysis

Quest Diagnostics (Comparative Multiple Analysis)


Notes on the Comparative Multiple Analysis of Quest Diagnostics

WikiWealth compares Quest Diagnostics's revenue, EBITDA, and EBIT multiples to their peers in order to determine the appropriate fair valuation. Click in the top right corner to experiment with Quest Diagnostics's comparative analysis.

Notes from the analysis:

1. WikiWealth uses quantitative measures to determine the multiple range for Quest Diagnostics.
2. Free cash flow to the firm (FCF) multiple is free cash flow to equity holders plus interest owed to Quest Diagnostics's debt holders.
3. Multiples incorporate benefits due to economies of scale; WikiWealth compares absolute enterprise value multiples to competitor's multiples.
4. WikiWealth excludes outliers when calculating individual company multiples.

Helpful Information for Quest Diagnostics's Analysis

How does this work? The Comparative Investment Analysis determines the value of Quest Diagnostics by comparing Quest Diagnostics financial ratios, prices, growth rates, margins, etc. to those of relevant peer groups.

Value Investing Importance? This method is widely used by investment professionals to determine the correct price of investments, especially initial public offerings (IPOs). It is one element of WikiWealth's three Wall Street approaches used to determine the correct fair value of Quest Diagnostics.

See the Quest Diagnostics cash flow (DCF) analysis for a completely different approach that's popular on Wall Street for determining the value of an investment in Quest Diagnostics.

Also, see the Quest Diagnostics's buffett intrinsic valuation analysis for WikiWealth's attempt to replicate the investing formula's used by Warren Buffett and Quest Diagnostics's valuation conclusion for a quick summary.